Clinical Trial Update: Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed evaluating Betaserc (betahistine) for vestibular compensation in patients with disabling Meniere's disease who underwent vest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease

Drugs mentioned

• Betaserc (betahistine)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Meniere's Disease | Phase 4 | Status: COMPLETED